Want Something to Short? Check Out this Healthcare Player
Jan 9th, 2009 | By Andrew Snyder | Category: Stock Market InvestingAll sorts of investors are look towards Obama to boost their portfolio. Unfortunately, the folks that have not done their homework will get burned. Investors across nearly every industry are looking towards President-elect Obama’s trillion-dollar stimulus for a near-immediate boost to their portfolio. Many of them are going to be severely disappointed in the next few months.
Obama’s stimulus proposal is filled with tax credits, accounting modifications and continuations of current tax laws set to expire. It has little in the way of direct financial stimulus to any industry, especially the healthcare industry.
The President-elect’s goal is to create jobs and reduce taxes in an effort to quickly revise consumer spending. In the short-term, his plan will boost infrastructure-related profits and create revenues for the nation’s “green” industries. But the money will not immediately flow through all sectors of the economy.
In fact, one of Obama’s favorite stomping points during his seemingly endless campaign was healthcare industry reform. It is widely know the Democrat wants to work towards a nationalized healthcare system.
Promises? What promises?
But now that revitalizing (or is it reviving?) the American economy has become top priority, the healthcare industry will be put on the back burner. The nation simply cannot afford the shockwaves of manipulating the financially vibrant sector. Unfortunately, many investors have not realized this point.
Take a look at Allscripts-Misys Healthcare Solutions (NASDAQ:MDRX), for instance. Profit-hungry investors are jumping all over this stock in hopes of getting in on Obama’s stimulus action. Unfortunately, they are making the plunge at a time when the stock is extremely vulnerable.
Later today, Allscripts will release its second-quarter earnings report. After all the attention this company has gotten over the last two months, even an iota of unexpected bad news could send shares on a downhill journey.
For investors willing to take on some speculation, this is a great opportunity to short sell shares of the stock. They could see strong profits as share price drops on any bad news.
If you are not willing to take on any unnecessary risk right now (I cannot blame you), keep a close eye on the stock’s action and be prepared to buy on any strong dips. Allscripts is a strong company with good products, but with its current share price of close to $9, is overvalued. Look to pick up shares in the $6 range.
Obama may be creating profit potential, but it is certainly not working out how he intends it to.
Source: Want something to short? Check out this healthcare player
Advertisement
At Hot Stock Confidential , we've averaged over 32% gains in just 26 trading days
42% on Nymox Pharmaceutical Corp....
23% on Emergent BioSolutions Inc....
38% on the first half of our position in a U.S. refiner...
26.68% on Synta Pharmaceuticals...
How's your favorite financial newsletter working out for you?
Hot Stock Confidential = Damn Good Stocks.
Learn more...